FDA Reuse Policy Demands Data From Both OEMs And Reprocessors
This article was originally published in The Gray Sheet
Executive Summary
FDA's revised policy on reprocessing of disposable medical devices would require manufacturers seeking to label a product as single-use only to submit data demonstrating that it cannot adequately be reprocessed, FDA staffers report.